Alertas Bibliograficas – Diabetes

Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targetsBenhalima K, Beunen K, Siegelaar S, Painter R, Murphy H Et AlLancet Diabetes Endocrinol. 2023 Jun...

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 UpdateSamson S, Vellanki P, Blonde L, Christofides E, Umpierrez G et alOn line 5 mayo 2023, Endocrine...

Impacts of COVID-19 on Glycemia and Risk of Diabetic KetoacidosisSharma A, Misra-Heberth A, Mariam A, Milinovich A, Onuzuruike, A et alDiabetes 2023;72(5):627–637https://doi.org/10.2337/db22-0264

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetesHeller S, Battelino, Bailey T, Pieber T, Pieber T et aldoi.org/10.1111/dom.14987

Management of adults with diabetes on dialysis: Summary of recommendations of the Joint British Diabetes Societies guidelines 2022Frankel A, Whaba M,  Ashworth V, Bedi R, Berrington et alhttps://doi.org/10.1111/dme.15027

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)Moser O,  Muller F, Aberer F, Aziz F; koizar H et alDiabetes Technol Ther. 2023...

Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.Feig D, Sanchez J, Murphy K, Astalos E, Zinman B, Sinmons D  et al.Lancet Diabetes...

Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled In Range trialBattelino T, Danne T, Edelman S, Choudhary P, Renard E et alDiabetes,...

Standards of Care in Diabetes-2023Diabetes Care December 2022, Vol.46, S1-S284https://doi.org/10.2337/dc23-Sint

Fasting and meal-stimulated serum C-peptide in long-standing type 1 diabetes mellitusVollenbrock C, Mul D, Dekker P, Birnie E, de Vries-Velraeds M, Boesten et alDiabetic Medicine https://www.doi.org/10.1111/dme.15012